ArticleCommunications chemistry2026
A deep learning framework (CreoPep) for target-specific design and optimization of conotoxin peptides.
Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep learning-driven discovery and mechanism of action study of a minimalist conopeptide targetingActa pharmaceutica Sinica. B · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Conotoxins are small, disulfide-rich peptides that display exceptional affinity and selectivity for ion channels and receptors, making them valuable templates for therapeutic development. However, their optimization remains challenging due to the limited diversity of naturally occurring variants and the labor-intensive nature of conventional engineering strategies. Here, we present CreoPep, a deep learning-based generative framework specifically developed to design and optimize conotoxins targeting defined receptors. CreoPep integrates masked language modeling with a progressive masking scheme and employs an augmentation pipeline that combines physics-based energy screening with temperature-controlled multinomial sampling. This enables the generation of structurally and functionally diverse peptide variants while retaining essential pharmacological features. Structural analysis shows that CreoPep-generated variants adopt both conserved and previously unobserved binding modes, including disulfide-deficient forms. Together, these findings establish CreoPep as a powerful computational-experimental framework for the rational design of conotoxin-based peptides and provide a foundation for extending similar approaches to other peptide families.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.